Make an Impact
Capitalize on Opportunity
FREE ROAD MAP TO FDA WHITE-PAPER
The ITC Transporter White Paper provides detailed guidance for transporter mediated DDI studies for the seven transporters recommended in the March 17, 2010 FDA Advisory Committee vote. Get the White Paper and a Road Map Summary to help navigate it.
QUESTIONS?
Speak with one of our DMPK specialists about your needs to understand how we can help you and the results you can expect.
CONTACT US:
888-OPTIVIA (888-678-4842)
Optivia Investors
Optivia is a capital-efficient commercial-stage company funded by the founders and experienced angel investors. Please contact us at (650)324-3177 ext. 11 for information on how you can make impact on drug discovery with an investment opportunity offered by Optivia.